We are live on ! Find out more
IIP

Intermede Investment Partners Portfolio holdings

AUM $2.16B
1-Year Est. Return 18.47%
This Fund
S&P 500
This Quarter Est. Return
+1.79%
1 Year Est. Return
+18.47%
3 Year Est. Return
+69.55%
5 Year Est. Return
+72.34%
10 Year Est. Return
+364.13%
AUM
$3.75B
AUM Growth
-$1.04B
Cap. Flow
-$1.06B
Cap. Flow %
-28.34%
Top 10 Hldgs %
49.76%
Holding
34
New
1
Increased
2
Reduced
30
Closed
1

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$118M
2
META icon
Meta Platforms (Facebook)
META
+$4.71M
3
SLB icon
SLB Ltd
SLB
+$2.77M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$83.9M
2
AMZN icon
Amazon
AMZN
+$80.1M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$75.9M
4
WST icon
West Pharmaceutical
WST
+$74.8M
5
ACN icon
Accenture
ACN
+$72.4M

Sector Composition

Rank Sector Weight
1 Technology 33.78%
2 Financials 17.3%
3 Communication Services 12.91%
4 Consumer Discretionary 11.4%
5 Industrials 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HDB icon
26
HDFC Bank
HDB
$121B
$81.4M 2.17%
2,548,696
-914,038
-26% -$29.2M
ANSS
27
DELISTED
Ansys
ANSS
$69.8M 1.86%
207,034
-57,349
-22% -$19.2M
COO icon
28
Cooper Companies
COO
$14.5B
$66.9M 1.79%
727,771
-366,302
-33% -$37.3M
SLB icon
29
SLB Ltd
SLB
$75B
$12.4M 0.33%
323,314
+65,900
+26% +$2.77M
GRAB icon
30
Grab
GRAB
$14.9B
$11.4M 0.3%
2,420,540
-727,115
-23% -$3.31M
DOX icon
31
Amdocs
DOX
$6.22B
$9.14M 0.24%
107,350
-1,096
-1% -$96.2K
AON icon
32
Aon
AON
$76B
$8.72M 0.23%
24,281
-196
-0.8% -$72.1K
MMYT icon
33
MakeMyTrip
MMYT
$5.64B
$8.12M 0.22%
72,300
-753
-1% -$80.7K
WST icon
34
West Pharmaceutical
WST
$24.9B
– –
-249,185
Closed -$74.8M
1
2

Similar funds

TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
NAAA
New Age Alpha Advisors Rye, New York $2.15B AUM 27.2% 1-Year Est. Return
SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
AAP
Aristotle Atlantic Partners Sarasota, Florida $2.14B AUM 37.01% 1-Year Est. Return

Intermede Investment Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Intermede Investment Partners held 34 positions worth $3.75B, down 22% from $4.79B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Intermede Investment Partners withdrew a net $1.06B in Q4 2024, closing 1 position and reducing 30 holdings. Its most notable exit was West Pharmaceutical, an estimated $74.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 30% a quarter earlier, followed by Financials and Communication Services.

Against the trend, Intermede Investment Partners opened a new position in Broadcom worth $148M.

  • Intermede Investment Partners's largest Q4 2024 buy was Broadcom: 638,188 shares worth $148M.
  • Intermede Investment Partners added most to Meta Platforms (Facebook) in Q4 2024, an estimated $4.71M increase.
  • Intermede Investment Partners's biggest Q4 2024 reduction was Linde, cutting an estimated $83.9M.
  • Intermede Investment Partners fully exited West Pharmaceutical in Q4 2024, selling an estimated $74.8M.
  • Intermede Investment Partners's ten largest holdings make up 50% of its $3.75B portfolio in Q4 2024.
  • Intermede Investment Partners opened 1 new position and closed 1 in Q4 2024.
  • Intermede Investment Partners's portfolio value fell 22% quarter-over-quarter to $3.75B.

Based on Intermede Investment Partners's 13F filing for Q4 2024, filed 10 Feb 2025.